PEACE-3 Trial Shows Combination Therapy Improves Survival in Prostate Cancer - report from ESMO2024

from Medical Digest & Congress Report · host Medical Congress News

Professor Silke Gillessen presented new results from the PEACE-3 trial at the 2024 ESMO conference. This study indicates that combining Enzalutamide with Radium223 significantly improves progression-free survival in patients with metastatic castration-resistant prostate cancer (mCRPC) and bone metastases over Enzalutamide alone. Video: https://medicaldigest.org/scientific-contents/interview:peace-3-trial-shows-combination-therapy-improves-survival-prostate-cancer-report-esmo2024

Episode metadata supplied by the publisher feed · Published Sep 28, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

PEACE-3 Trial Shows Combination Therapy Improves Survival in Prostate Cancer - report from ESMO2024

0:00 5:08

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 5 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on September 28, 2024.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!